S2Medical

S2Medical is a Swedish medical technology company specializing in advanced wound care, particularly for the treatment of burns and chronic wounds. The company develops and markets innovative products such as Epiprotect, a synthetic skin substitute based on bio-cellulose that promotes healing and reduces pain for patients with severe skin injuries. Their portfolio includes a range of dressings, debridement tools, and grafting technologies designed to improve clinical outcomes and reduce healthcare costs. S2Medical operates its own production facility in Sweden and maintains a strong focus on research and development to expand its product line. The company is publicly traded on the Nasdaq First North Growth Market and has a significant commercial presence in Europe and the Middle East.